BSG and cancer: Since these cancers still have proven intractable with limited treatment options and remain difficult to cure even by the recent advances in drug development, our results warrant the further investigations whether this novel anti-CD147 antibody may have the potential to dissolve the current unmet needs for these intractable cancers.